Cargando…

Upper Airway Disease: Rhinitis and Rhinosinusitis

Detalles Bibliográficos
Autores principales:	Scadding, Glenis K., Kariyawasam, Harsha H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173438/ http://dx.doi.org/10.1016/B978-1-4557-0792-8.00037-4

Ejemplares similares

Chronic Rhinosinusitis: Therapeutic Efficacy of Anti-Inflammatory and Antibiotic Approaches
por: Kariyawasam, Harsha H, et al.
Publicado: (2011)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

Rhinitis, sinusitis and ocular disease – 2091. The MSYPQ: repeatability and applicability to rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

Rhinitis and Sinusitis
por: Scadding, Glenis K.
Publicado: (2008)

Optimal management of allergic rhinitis
por: Scadding, Glenis K
Publicado: (2015)

Allergic Rhinitis, Asthma, and Rhinosinusitis: Diseases of the Integrated Airway
por: Meltzer, Eli O., et al.
Publicado: (2004)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

Pathophysiological and Clinical Aspects of Chronic Rhinosinusitis: Current Concepts
por: Vlaminck, Stephan, et al.
Publicado: (2021)

Treatment of congestion in upper respiratory diseases
por: Meltzer, Eli O, et al.
Publicado: (2010)

The microbiome of the upper airways: focus on chronic rhinosinusitis
por: Chalermwatanachai, Thanit, et al.
Publicado: (2015)

Assessment of disease control in allergic rhinitis
por: Demoly, Pascal, et al.
Publicado: (2013)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis
por: Leaker, Brian R., et al.
Publicado: (2015)

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
por: Hox, Valerie, et al.
Publicado: (2020)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice
por: Santos, Alexandra F, et al.
Publicado: (2015)

Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
por: Hox, Valerie, et al.
Publicado: (2020)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

The Prevalence of Allergic Rhinitis in Patients with Chronic Rhinosinusitis
por: Bakhshaee, Mehdi, et al.
Publicado: (2014)

Aeroallergens, air pollutants, and chronic rhinitis and rhinosinusitis
por: London, Nyall R., et al.
Publicado: (2018)

Molecular Mechanisms of Nasal Epithelium in Rhinitis and Rhinosinusitis
por: Toppila-Salmi, Sanna, et al.
Publicado: (2014)

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
por: Janosova, Viera, et al.
Publicado: (2020)

Progression of Rhinitis to Rhinosinusitis: A Cohort Study
por: van Schie, Bram, et al.
Publicado: (2023)

Rhinitis, sinusitis and ocular disease – 2092. The MSNOT-20 questionnaire: repeatability and disease analysis of rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

Grand Challenges in Rhinology
por: Scadding, Glenis K.
Publicado: (2020)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

Allergens, germs and asthma
por: Scadding, Glenis Kathleen
Publicado: (2015)

P07 - Treatment load in the therapy management of allergic rhinitis: a UK retrospective database study
por: Carter, Victoria, et al.
Publicado: (2014)

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
por: Price, David B, et al.
Publicado: (2016)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

Bidirectional link between upper and lower airways in patients with allergic rhinitis
por: Bencova, A, et al.
Publicado: (2009)

A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
por: Scadding, Glenis Kathleen
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fr0ii0dmn2ct1u5qa7jgh1ppsr